Fibrogen FG-3246 Phase 1 Study Results in Metastatic Prostate Cancer
FibroGen announced positive results from a Phase 1 study of FG-3246, an antibody-drug conjugate targeting CD46, in patients with...
Jon Napitupulu
Anthos Therapeutics Shares New Data from Landmark AZALEA-TIMI 71 Study
Anthos Therapeutics presented new analyses from the AZALEA-TIMI 71 study at the American College of Cardiology Annual Scientific Session....
Bentracimab Reverses Ticagrelor Effects in Phase 3 Trial
SFJ Pharmaceuticals and SERB Pharmaceuticals announced positive final results from the Phase 3 REVERSE-IT trial of bentracimab, a ticagrelor...
Ninerafaxstat Improves Cardiometabolic HFpEF in Phase 2 Trial
Imbria Pharmaceuticals announced positive Phase 2 trial results for ninerafaxstat in patients with cardiometabolic heart failure with preserved ejection...
Aavant-Garde & TIGEM’s Groundbreaking Research in Science Advances
AAVantgarde Bio, in collaboration with the Telethon Institute of Genetics and Medicine (TIGEM), published preclinical research in Science Advances...
Vaxcyte Announces Positive VAX-24 Infant Phase 2 Results
Vaxcyte, a clinical-stage vaccine company, will present topline results from its Phase 2 infant study of VAX-24, a 24-valent...
Promising Early Data from NBTXR3 Phase 1 Study in Advanced NSCLC
Nanobiotix announced positive Phase 1 data for NBTXR3 (JNJ-1900), a radiotherapy-activated nanoparticle therapy, in patients with locally advanced non-small...
Promising Portage Biotech Preclinical Results Support Trial
Portage Biotech presented preclinical data for PORT-7 (TT-4), a selective A2B adenosine receptor inhibitor, at the 2025 European Lung...
EMA Validates Paltusotine MAA for Acromegaly
Crinetics Pharmaceuticals announced that the European Medicines Agency (EMA) validated its Marketing Authorization Application (MAA) for paltusotine to treat...
Sensei Reports Positive Solnerstotug Data in Resistant Tumors
Sensei Biotherapeutics announced preliminary positive results from the dose expansion portion of its Phase 1/2 trial of solnerstotug, a...